Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
allergan
alnylam pharmaceuticals
ambys medicines
american academy of neurology
amgen
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
atogepant
biohaven
What
drug
2
×
drugs
2
×
fda
2
×
approval
aren’t
arguments
big
bio
class
commercialized
companies
competitors
decades
developers
gene
help
imminent
long
make
medicare
meeting
migraine
moves
neuro
new
news
noteworthy
oral
patients
potential
prices
road
roundup
rulings
separate
therapies
therapy
they’ll
winding
won
Language
Current search:
xconomy.com
×
drugs
×
fda
×
drug
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
